Cellular monitoring of the nuclear factor κB pathway for assessment of space environmental radiation

Radiation Research

Volumn 164, Issue 4 II, 2005, Pages 527-530

  Baumstark Khan, Christa ^a   Hellweg, Christine E ^a   Arenz, Andrea ^a   Meier, Matthias M ^a  

^a GERMAN AEROSPACE CENTER DLR   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON; ENHANCED GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ACCELERATION; BIOLOGICAL MONITORING; CELL NUCLEUS; CONFERENCE PAPER; CONTROLLED STUDY; COSMIC RADIATION; DENSITY; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL RADIOACTIVITY; FLOW CYTOMETRY; GENE ACTIVATION; GENE INDUCTION; HEAVY ION RADIATION; HUMAN; HUMAN CELL; NUCLEON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RADIATION EXPOSURE; SCREENING TEST;

CELL LINE; COSMIC RADIATION; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAVY IONS; HUMANS; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 25444469964     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3397.1     Document Type: Conference Paper

References (25)

1. S. B. Curtis and J. R. Letaw. Galactic cosmic rays and cell-hit frequencies outside the magnetosphere. Adv. Space Res. 9, 293-298 (1989).
2. N. J. Holbrook, Y. Liu and A. J. Fornace. Signaling events controlling the molecular response to genotoxic stress. In Stress-Inducible Cellular Responses (U. Feige, R. I. Morimoto, I. Yahara and B. S. Polla, Eds.), pp. 273-288. Birkhauser, Basel, Switzerland, 1996.
3. D. Durocher and S. P. Jackson. DNA-PK, ATM and ATR as sensors of DNA damage: Variations on a theme? Curr. Opin. Cell Biol. 13, 225-231 (2001).
4. R. Schreck, P. Rieber and P. A. Baeuerle. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10, 2247-2258 (1991).
5. P. J. Barnes and M. Karin. Nuclear factor kappa B: A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071 (1997).
6. M. Wu, H. Lee, R. E. Bellas,. S. L. Schauer, A. M. Arsura, D. Katz, M. J. Fitzgerald, T. L. Rothstein, D. H. Sherr and G. E. Sonnenshein. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15, 4682-4690 (1996).
7. G. E. Sonnenshein. Rel/NF-κB transcription factors and the control of apoptosis. Semin. Cancer Biol. 8, 113-119 (1997).
8. U. Zabel, T. Henkel, M. S. Silva and P. A. Baeuerle. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12, 201-211 (1993).
9. I. Alkalay, A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover and Y. Ben-Neriah. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92, 10599-10603 (1995).
10. S. Ghosh, M. J. May and E. B. Kopp. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260 (1998).
11. V. R. Baichwal and P. A. Baeuerle. Activate NF-κB or die. Curr. Biol. 7, R94-R96 (1997).
12. B. Piret, S. Schoonbroodt and J. Piette. The ATM protein is required for sustained activation of NF-κB following DNA damage. Oncogene 18, 2261-2271 (1999).
13. N. Li, S. Banin, H. Ouyang, G. C. Li, G. Courtoisi, Y. Shiloh, M. Karin and G. Rotman. ATM is required for IκB kinase (IKK) activation in response to DNA double strand breaks. J. Biol. Chem. 276, 8898-8903 (2001).
14. C. Y. Wang, M. W. Mayo, R. G. Korneluk, D. V. Goeddel and A. S. Baldwin Jr.. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683 (1998).
15. A. S. Baldwin, Jr., Control of ontogenesis and cancer therapy resistance by the transcription factor NF-κB. J. Clin. Invest. 107, 241-246 (2001).
16. D. C. Duffey, Z. Chen, G. Dong, F. G. Ondrey, J. S. Woff, K. Brown, U. Siebenlist and C. Van Waes. Expression of a dominant-negative mutant inhibitor-Bα of nuclear factor-κ;B in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res. 59, 3468-3474 (1999).
17. H. L. Pahl. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866 (1999).
18. N. Li and M. Karin. Is NF-κB the sensor of oxidative stress? FASEB J. 13, 1137-1143 (1999).
19. C. E. Hellweg, C. Baumstark-Khan and G. Horneck. Generation of stably transfected mammalian cell lines as fluorescent NF-κB activation reporter assay. J. Biomol. Screen. 8, 511-521 (2003).
20. X. Li, X. Zhao, Y. Fang, X. Jiang, T. Duong, C. Fan, C. C. Huang and S. R. Kain. Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273, 34970-34975 (1998).
21. F. L. Graham, J. Smiley, W. C. Russell and R. Nairn. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74 (1977).
22. P. A. Baeuerle and D. Baltimore. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53, 211-217 (1988).
23. D. Tobin, M. van Hogerlinden and R. Toftgard. UVB-induced association of tumor necrosis factor (TNF) receptor 1/TNF receptor-associated factor-2 mediates activation of Rel proteins. Proc. Natl. Acad. Sci. USA 95, 565-569 (1998).
24. M. Natarajan, N. Aravindan, M. L. Meltz and T. S. Herman. Posttranslational modification of I-κB alpha activates NF-κB in human monocytes exposed to 56-Fe ions. Radiat. Environ. Biophys. 41, 139-144 (2002).
25. J. R. Williams, Y. Zhang, H. Zhou, M. Osman, D. Cha, R. Kavet, F. Cucinotta, J. F. Dicello and L. E. Dillehay. Predicting cancer rates in astronauts from animal carcinogenesis studies and cellular markers. Mutat. Res. 430, 255-269 (1999).